Publications
Found 9 results
Filters: Author is Z. Xu [Clear All Filters]
, “Relationship between C-reactive protein levels and obstructive sleep apnea syndrome”, vol. 15, p. -, 2016.
, “Relationship between C-reactive protein levels and obstructive sleep apnea syndrome”, vol. 15, p. -, 2016.
, “Muscle pain, fever, cough, and progressive dyspnea in a woman with eosinophilic pneumonia”, vol. 14. pp. 4189-4194, 2015.
, “Pooled analysis of association between a genetic variant in the 3'-untranslated region of Toll-like receptor 4 and cancer risk”, vol. 14, pp. 17847-17855, 2015.
, “Characterization of Chinese eggplant isolates of the fungal pathogen Verticillium dahliae from different geographic origins”, vol. 12, pp. 183-195, 2013.
Arora DK, Hirsch PR and Kerry BR (1996). PCR-based molecular discrimination of Verticillium chlamydosporium isolates. Mycol. Res. 100: 801-809.
http://dx.doi.org/10.1016/S0953-7562(96)80025-6
Bejarano-Alcázar J, Blanco-López MA, Melero-Vara JM and Jiménez-Díaz RM (1996). Etiology, importance, and distribution of Verticillium wilt of cotton in southern Spain. Plant Dis. 80: 1233-1238.
http://dx.doi.org/10.1094/PD-80-1233
Bell AA (1994). Mechanisms of Disease Resistance in Gossypium Species and Variation in Verticillium dahliae. In: Challenging the Future: Proceedings of World Cotton Research Conference 1 (Constable GA and Forrester NW, eds.). CSIRO, Melbourne, 225-235.
Bhat RG and Subbarao KV (1999). Host Range Specificity in Verticillium dahliae. Phytopathology 89: 1218-1225.
http://dx.doi.org/10.1094/PHYTO.1999.89.12.1218
PMid:18944648
Carder JH and Barbara DJ (1991). Molecular variation and restriction fragment length polymorphisms (RFLPs) within and between six species of Verticillium. Mycol. Res. 95: 935-942.
http://dx.doi.org/10.1016/S0953-7562(09)80090-7
Carder JH and Barbara DJ (1994). Molecular variation within some Japanese isolates of Verticillium dahliae. Plant Pathol. 43: 947-950.
http://dx.doi.org/10.1111/j.1365-3059.1994.tb01642.x
Dobinson KF, Patterson NA, White GJ and Grant S (1998). DNA fingerprinting and vegetative compatibility analysis indicate multiple origins for Verticillium dahliae race 2 tomato isolates from Ontario, Canada. Mycol. Res. 102: 1089-1095.
http://dx.doi.org/10.1017/S0953756297006035
Elena K and Paplomatas EJ (1998). Vegetative compatibility groups within Verticillium dahliae isolates from different hosts in Greece. Plant Pathol. 47: 635-640.
http://dx.doi.org/10.1046/j.1365-3059.1998.00273.x
Fradin EF and Thomma BP (2006). Physiology and molecular aspects of Verticillium wilt diseases caused by V. dahliae and V. albo-atrum. Mol. Plant Pathol. 7: 71-86.
http://dx.doi.org/10.1111/j.1364-3703.2006.00323.x
PMid:20507429
Gennari SD, Ercole N and Mirotti A (2000). Vegetative Compatibility Groupings Among Verticillium dahliae Kleb. Isolates from Vegetable Crops. In: Advances in Verticillium: Research and Disease Management (Tjamos EC, Rowe RC, Heale JB and Fravel DR, eds.). APS Press, St. Paul, 112-116.
Grünig CR, Sieber TN and Holdenrieder O (2001). Characterisation of dark septate endophytic fungi (DSE) using inter-simple-sequence-repeat-anchored polymerase chain reaction (ISSR-PCR) amplification. Mycol. Res. 105: 24-32.
http://dx.doi.org/10.1017/S0953756200003658
Hagiwara H (1990). Differentiation of the pathogenicity of Verticillium dahliae in Japan. Plant Prot. 44: 299-303.
Hall RA (1984). Epizootic potential for aphids of different isolates of the fungus Verticillium lecanii. Entomophaga 29: 311-321.
http://dx.doi.org/10.1007/BF02372119
Hiemstra JA and Rataj-Guranowska M (2000). Vegetative Compatibility Groups in Verticillium dahliae in the Netherlands. In: Advances in Verticillium: Research and Disease Management. (Tjamos EC, Rowe RC, Heale JB and Fravel DR, eds.). APS Press, St. Paul, 100-102.
Joaquim TR and Rowe RC (1990). Reassessment of vegetative compatibility relationships among strains of Verticillium dahliae using nitrate-nonutilizing mutants. Phytopathology 80: 1160-1166.
http://dx.doi.org/10.1094/Phyto-80-1160
Joaquim TR and Rowe RC (1991). Vegetative compatibility and virulence of strains of Verticillium dahliae from soil and potato plants. Phytopathology 81: 552-558.
http://dx.doi.org/10.1094/Phyto-81-552
Kadow KJ (1934). Seed transmission of Verticillium wilt of eggplants and tomatoes. Phytopathology 24: 1265-1268.
Klosterman SJ, Atallah ZK, Vallad GE and Subbarao KV (2009). Diversity, pathogenicity, and management of Verticillium species. Annu. Rev. Phytopathol. 47: 39-62.
http://dx.doi.org/10.1146/annurev-phyto-080508-081748
PMid:19385730
Koike M, Fujita M, Nagao H and Ohshima S (1996). Random amplified polymorphic DNA analysis of Japanese isolates of Verticillium dahliae and V. albo-atrum. Plant Dis. 80: 1224-1227.
http://dx.doi.org/10.1094/PD-80-1224
Komatsu T, Sumino A and Kageyama K (2001). Characterization of Verticillium dahliae isolates from potato on Hokkaido by random amplified polymorphic DNA (RAPD) and REP-PCR analyses. J. Gen. Plant Pathol. 67: 23-27.
http://dx.doi.org/10.1007/PL00012982
Lee SB and Taylor JW (1990). Isolation of DNA from Fungal Mycelia and Single Spores. In: PCR Protocols: A Guide to Methods and Applications (Innis MA, Gelfand DH, Sninsky JJ and White TJ, eds.). Academic Press, San Diego, 282-287.
Masuda T and Kikuchi O (1992). Pathogenicity of Verticillium lecanii isolates to whitefly and aphids. Jap. J. Appl. Entomol. Zool. 36: 239-245.
http://dx.doi.org/10.1303/jjaez.36.239
Nei M (1979). Proportion of informative families for genetic counseling with linked marker genes. Jinrui. Idengaku. Zasshi 24: 131-142.
http://dx.doi.org/10.1007/BF01888684
PMid:299082
Okoli CAN, Carder JH and Barbara DJ (1993). Molecular variation and sub-specific groupings within Verticillium dahliae. Mycol. Res. 97: 233-239.
http://dx.doi.org/10.1016/S0953-7562(09)80246-3
Okoli CAN, Carder JH and Barbara DJ (1994). Restriction fragment length polymorphisms (RFLPs) and the relationships of some host-adapted isolates of Verticillium dahliae. Plant Pathol. 43: 33-40.
http://dx.doi.org/10.1111/j.1365-3059.1994.tb00550.x
Pérez-Artés E, García-Pedrajas MD, Bejarano-Alcázar J and Jiménez-Díaz RM (2000). Differentiation of cotton-defoliating and nondefoliating pathotypes of Verticillium dahliae by RAPD and specific PCR analyses. Eur. J. Plant Pathol. 106: 507-517.
http://dx.doi.org/10.1023/A:1008756307969
Presley JT (1969). Growth response of Verticillium albo-atrum to sanguinarine in nutrient agar. Phytopathology 59: 1968-1969.
Puhalla JE and Hummel M (1983). Vegetative compatibility groups within Verticillium dahliae. Phytopathology 73: 1305-1308.
http://dx.doi.org/10.1094/Phyto-73-1305
Ramsay JR, Multani DS and Lyon BR (1996). RAPD-PCR identification of Verticillium dahliae isolates with differential pathogenicity on cotton. Aust. J. Agri. Res. 47: 681-693.
http://dx.doi.org/10.1071/AR9960681
Rodrigues KF, Sieber TN, Grunig CR and Holdenrieder O (2004). Characterization of Guignardia mangiferae isolated from tropical plants based on morphology, ISSR-PCR amplifications and ITS1-5.8S-ITS2 sequences. Mycol. Res.108: 45-52.
http://dx.doi.org/10.1017/S0953756203008840
PMid:15035504
Schnathorst WC and Mathre DE (1966). Host range and differentiation of a severe form of Verticillium albo-atrum in cotton. Phytopathology 56: 1155-1161.
Usami T, Abiko M, Shishido M and Amemiya Y (2002). Specific detection of tomato pathotype of Verticillium dahliae by PCR assays. J. Gen. Plant Pathol. 68: 134-140.
http://dx.doi.org/10.1007/PL00013066
Wang S, Miao X, Zhao W, Huang B, et al. (2005). Genetic diversity and population structure among strains of the entomopathogenic fungus, Beauveria bassiana, as revealed by inter-simple sequence repeats (ISSR). Mycol. Res. 109: 1364-1372.
http://dx.doi.org/10.1017/S0953756205003709
PMid:16353636
Wilhelm S (1955). Longevity of the Verticillium wilt fungus in the laboratory and field. Phytopathology 45: 180-181.
Xiao YH and Lin BQ (1995). Identification of Verticillium wilt resistance on eggplant germplasm. Chin. Veg. 1: 32-33.
Yi J (1998). Advances of breeding on eggplant for Verticillium wilt resistance. Chin. Veg. 6: 52-55.
Yi J, Chen J and Gao J (2000). Evaluation of Verticillium wilt resistance on eggplant germplasm (Chinese). Jiangsu Agri. Sci. 6: 54-57.
Zietkiewicz E, Rafalski A and Labuda D (1994). Genome fingerprinting by simple sequence repeat (SSR)-anchored polymerase chain reaction amplification. Genomics 20: 176-183.
http://dx.doi.org/10.1006/geno.1994.1151
PMid:8020964
, “Correlation of growth-related traits and their effects on body weight of the mud crab (Scylla paramamosain)”, vol. 12, pp. 4127-4136, 2013.
, “Mutational analysis of AXIN2, MSX1, and PAX9 in two Mexican oligodontia families”, vol. 12, pp. 4446-4458, 2013.
, “Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk”, vol. 11, pp. 3389-3397, 2012.
Baniyash M (2006). Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin. Cancer Biol. 16: 80-88.
http://dx.doi.org/10.1016/j.semcancer.2005.12.002
PMid:16420981
Breslow NE and Day NE (1987). Statistical methods in cancer research. Volume II - The design and analysis of cohort studies. IARC Sci. Publ.1-406.
Bulpitt EA, Baynesc C, Dunning AM, Evans PR, et al. (2004). Investigation of interleukin-10 and vascular endothelial growth factor single nucleotide polymorphisms in predisposition to breast cancer. Genes Immun. 5: S1-S53.
Cacev T, Radosevic S, Krizanac S and Kapitanovic S (2008). Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29: 1572-1580.
http://dx.doi.org/10.1093/carcin/bgn164
PMid:18628251
Chan AT, Ogino S and Fuchs CS (2007). Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N. Engl. J. Med. 356: 2131-2142.
http://dx.doi.org/10.1056/NEJMoa067208
PMid:17522398
Cozar JM, Romero JM, Aptsiauri N, Vazquez F, et al. (2007). High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum. Immunol. 68: 698-704.
http://dx.doi.org/10.1016/j.humimm.2007.05.002
PMid:17678726
Crawley E, Kay R, Sillibourne J, Patel P, et al. (1999). Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 42: 1101-1108.
http://dx.doi.org/10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y
Crivello A, Giacalone A, Vaglica M, Scola L, et al. (2006). Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. Ann. N. Y. Acad. Sci. 1089: 98-103.
http://dx.doi.org/10.1196/annals.1386.002
PMid:17261758
Crohn BB and Rosenberg H (1925). The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am. J. Med. Sci. 170: 220-228.
http://dx.doi.org/10.1097/00000441-192508010-00006
De Vita F, Orditura M, Galizia G, Romano C, et al. (1999). Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer 86: 1936-1943.
http://dx.doi.org/10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9
Eskdale J, Kube D, Tesch H and Gallagher G (1997). Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics 46: 120-128.
http://dx.doi.org/10.1007/s002510050250
PMid:9162098
Eskdale J, Gallagher G, Verweij CL, Keijsers V, et al. (1998). Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc. Natl. Acad. Sci. U. S. A. 95: 9465-9470.
http://dx.doi.org/10.1073/pnas.95.16.9465
PMid:9689103 PMCid:21361
Gunter MJ, Canzian F, Landi S, Chanock SJ, et al. (2006). Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol. Biomarkers Prev. 15: 1126-1131.
http://dx.doi.org/10.1158/1055-9965.EPI-06-0042
PMid:16775170
Hanada T and Yoshimura A (2002). Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13: 413-421.
http://dx.doi.org/10.1016/S1359-6101(02)00026-6
Howell WM and Rose-Zerilli MJ (2007). Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J. Nutr. 137: 194S-199S.
PMid:17182825
Lakatos PL and Lakatos L (2008). Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J. Gastroenterol. 14: 3937-3947.
http://dx.doi.org/10.3748/wjg.14.3937
PMid:18609676 PMCid:2725331
Lee YS, Choi HB, Lee IK, Kim TG, et al. (2010). Association between interleukin-4R and TGF-beta1 gene polymorphisms and the risk of colorectal cancer in a Korean population. Colorectal Dis. 12: 1208-1212.
http://dx.doi.org/10.1111/j.1463-1318.2009.02080.x
PMid:19863607
Macarthur M, Sharp L, Hold GL, Little J, et al. (2005). The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol. Biomarkers Prev. 14: 1613-1618.
http://dx.doi.org/10.1158/1055-9965.EPI-04-0878
PMid:16030091
Midgette AS, Wong JB, Beshansky JR, Porath A, et al. (1994). Cost - Effectiueness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Med. Decis. Making 14: 108-117.
http://dx.doi.org/10.1177/0272989X9401400203
PMid:8028463
Shin HD, Park BL, Kim LH, Jung JH, et al. (2003). Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum. Mol. Genet. 12: 901-906.
http://dx.doi.org/10.1093/hmg/ddg104
PMid:12668613
Siegel R, Naishadham D and Jemal A (2012). Cancer statistics, 2012. CA Cancer J. Clin. 62: 10-29.
http://dx.doi.org/10.3322/caac.20138
PMid:22237781
Sturlan S, Oberhuber G, Beinhauer BG, Tichy B, et al. (2001). Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development. Carcinogenesis 22: 665-671.
http://dx.doi.org/10.1093/carcin/22.4.665
PMid:11285204
Talseth BA, Meldrum C, Suchy J, Kurzawski G, et al. (2007). Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer. Scand. J. Gastroenterol. 42: 628-632.
http://dx.doi.org/10.1080/00365520601106699
PMid:17454884
Triantafillidis JK, Nasioulas G and Kosmidis PA (2009). Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 29: 2727-2737.
PMid:19596953
Tsilidis KK, Helzlsouer KJ, Smith MW, Grinberg V, et al. (2009). Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control. 20: 1739-1751.
http://dx.doi.org/10.1007/s10552-009-9427-7
PMid:19760027
Tuynman JB, Peppelenbosch MP and Richel DJ (2004). COX-2 inhibition as a tool to treat and prevent colorectal cancer. Crit. Rev. Oncol. Hematol. 52: 81-101.
PMid:15501074
Vidal-Vanaclocha F (2009). Inflammation in the molecular pathogenesis of cancer and atherosclerosis. Reumatol. Clin. 5S1: 40-43.
Vogel U, Christensen J, Dybdahl M, Friis S, et al. (2007). Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat. Res. 624: 88-100.
http://dx.doi.org/10.1016/j.mrfmmm.2007.04.006
PMid:17544013
Wilkening S, Tavelin B, Canzian F, Enquist K, et al. (2008). Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis 29: 1202-1206.
http://dx.doi.org/10.1093/carcin/bgn101
PMid:18448485
Xie J and Itzkowitz SH (2008). Cancer in inflammatory bowel disease. World J. Gastroenterol. 14: 378-389.
http://dx.doi.org/10.3748/wjg.14.378
PMid:18200660 PMCid:2679126
Zheng C, Huang D, Liu L, Wu R, et al. (2001). Interleukin-10 gene promoter polymorphisms in multiple myeloma. Int. J. Cancer 95: 184-188.
http://dx.doi.org/10.1002/1097-0215(20010520)95:3<184::AID-IJC1031>3.0.CO;2-V
, “Phenotype characterization and sequence analysis of BMP2 and BMP4 variants in two Mexican families with oligodontia”, vol. 11, pp. 4110-4120, 2012.
Aberg T, Wozney J and Thesleff I (1997). Expression patterns of bone morphogenetic proteins (Bmps) in the developing mouse tooth suggest roles in morphogenesis and cell differentiation. Dev. Dyn. 210: 383-396.
http://dx.doi.org/10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C
Arte S, Nieminen P, Apajalahti S, Haavikko K, et al. (2001). Characteristics of incisor-premolar hypodontia in families. J. Dent. Res. 80: 1445-1450.
http://dx.doi.org/10.1177/00220345010800051201
PMid:11437217
Bei M, Kratochwil K and Maas RL (2000). BMP4 rescues a non-cell-autonomous function of Msx1 in tooth development. Development 127: 4711-4718.
PMid:11023873
Capasso M, Ayala F, Russo R, Avvisati RA, et al. (2009). A predicted functional single-nucleotide polymorphism of bone morphogenetic protein-4 gene affects mRNA expression and shows a significant association with cutaneous melanoma in Southern Italian population. J. Cancer Res. Clin. Oncol. 135: 1799-1807.
http://dx.doi.org/10.1007/s00432-009-0628-y
PMid:19557432
Chen S, Gluhak-Heinrich J, Martinez M, Li T, et al. (2008). Bone morphogenetic protein 2 mediates dentin sialophosphoprotein expression and odontoblast differentiation via NF-Y signaling. J. Biol. Chem. 283: 19359- 19370.
http://dx.doi.org/10.1074/jbc.M709492200
PMid:18424784 PMCid:2443643
Choi JY, Shin CS, Hong YC and Kang D (2006). Single-nucleotide polymorphisms and haplotypes of bone morphogenetic protein genes and peripheral bone mineral density in young Korean men and women. Calcif. Tissue Int. 78: 203-211.
http://dx.doi.org/10.1007/s00223-005-0139-z
PMid:16604289
Feng J, Yang G, Yuan G, Gluhak-Heinrich J, et al. (2011). Abnormalities in the enamel in bmp2-deficient mice. Cells Tissues Organs 194: 216-221.
http://dx.doi.org/10.1159/000324644
PMid:21597270 PMCid:3178081
Frazier-Bowers SA, Scott MR, Cavender A, Mensah J, et al. (2002). Mutational analysis of families affected with molar oligodontia. Connect. Tissue Res. 43: 296-300.
PMid:12489173
Gabris K, Tarjan I, Csiki P, Konrad F, et al. (2001). Prevalence of congenital hypodontia in the permanent dentition and its treatment. Fogorv. Sz. 94: 137-140.
PMid:11573454
Gerits A, Nieminen P, De MS and Carels C (2006). Exclusion of coding region mutations in MSX1, PAX9 and AXIN2 in eight patients with severe oligodontia phenotype. Orthod. Craniofac. Res. 9: 129-136.
http://dx.doi.org/10.1111/j.1601-6343.2006.00367.x
PMid:16918677
Gluhak-Heinrich J, Guo D, Yang W, Harris MA, et al. (2010). New roles and mechanism of action of BMP4 in postnatal tooth cytodifferentiation. Bone 46: 1533-1545.
http://dx.doi.org/10.1016/j.bone.2010.02.024
PMid:20206312 PMCid:2875306
Han D, Gong Y, Wu H, Zhang X, et al. (2008). Novel EDA mutation resulting in X-linked non-syndromic hypodontia and the pattern of EDA-associated isolated tooth agenesis. Eur. J. Med. Genet. 51: 536-546.
http://dx.doi.org/10.1016/j.ejmg.2008.06.002
PMid:18657636
Kapadia H, Mues G and D'Souza R (2007). Genes affecting tooth morphogenesis. Orthod. Craniofac. Res. 10: 237-244.
http://dx.doi.org/10.1111/j.1601-6343.2007.00407.x
PMid:17973693
Kong H, Wang Y, Patel M, Mues G, et al. (2011). Regulation of bmp4 expression in odontogenic mesenchyme: from simple to complex. Cells Tissues Organs 194: 156-160.
http://dx.doi.org/10.1159/000324747
PMid:21546760 PMCid:3178073
Lammi L, Halonen K, Pirinen S, Thesleff I, et al. (2003). A missense mutation in PAX9 in a family with distinct phenotype of oligodontia. Eur. J. Hum. Genet. 11: 866-871.
http://dx.doi.org/10.1038/sj.ejhg.5201060
PMid:14571272
Lawson KA, Dunn NR, Roelen BA, Zeinstra LM, et al. (1999). Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev. 13: 424-436.
http://dx.doi.org/10.1101/gad.13.4.424
PMid:10049358 PMCid:316469
Lin JY, Chen YJ, Huang YL, Tang GP, et al. (2008). Association of bone morphogenetic protein 4 gene polymorphisms with nonsyndromic cleft lip with or without cleft palate in Chinese children. DNA Cell Biol. 27: 601-605.
http://dx.doi.org/10.1089/dna.2008.0777
PMid:18771417
Liu W, Dong X, Mai M, Seelan RS, et al. (2000). Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat. Genet. 26: 146-147.
http://dx.doi.org/10.1038/79859
PMid:11017067
Meng XL, Wang H, Yang H, Hai Y, et al. (2010). T allele at site 6007 of bone morphogenetic protein-4 gene increases genetic susceptibility to ossification of the posterior longitudinal ligament in male Chinese Han population. Chin. Med. J. 123: 2537-2542.
Nieminen P (2009). Genetic basis of tooth agenesis. J. Exp. Zool. B Mol. Dev. Evol. 312B: 320-342.
Nieminen P, Pekkanen M, Aberg T and Thesleff I (1998). A graphical www-database on gene expression in tooth. Eur. J. Oral Sci. 106: 7-11.
PMid:9541196
Noor A, Windpassinger C, Vitcu I, Orlic M, et al. (2009). Oligodontia is caused by mutation in LTBP3, the gene encoding latent TGF-beta binding protein 3. Am. J. Hum. Genet. 84: 519-523.
http://dx.doi.org/10.1016/j.ajhg.2009.03.007
PMid:19344874 PMCid:2667979
Ramesh BL, Wilson SG, Dick IM, Islam FM, et al. (2005). Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone 36: 555-561.
http://dx.doi.org/10.1016/j.bone.2004.12.005
PMid:15777683
Scarel RM, Trevilatto PC, Di Hipólito O Jr, Camargo LE, et al. (2000). Absence of mutations in the homeodomain of the MSX1 gene in patients with hypodontia. Am. J. Med. Genet. 92: 346-349.
http://dx.doi.org/10.1002/1096-8628(20000619)92:5<346::AID-AJMG10>3.0.CO;2-A
Schalk-van der Weide Y, Steen WH and Bosman F (1992). Distribution of missing teeth and tooth morphology in patients with oligodontia. ASDC J. Dent. Child. 59: 133-140.
PMid:1583198
Schrauwen I, Thys M, Vanderstraeten K, Fransen E, et al. (2008). Association of bone morphogenetic proteins with otosclerosis. J. Bone Miner. Res. 23: 507-516.
http://dx.doi.org/10.1359/jbmr.071112
PMid:18021008 PMCid:2669162
Stockton DW, Das P, Goldenberg M, D'Souza RN, et al. (2000). Mutation of PAX9 is associated with oligodontia. Nat. Genet. 24: 18-19.
http://dx.doi.org/10.1038/71634
PMid:10615120
Thesleff I (2003). Epithelial-mesenchymal signalling regulating tooth morphogenesis. J. Cell Sci. 116: 1647-1648.
http://dx.doi.org/10.1242/jcs.00410
PMid:12665545
Thomadakis G, Ramoshebi LN, Crooks J, Rueger DC, et al. (1999). Immunolocalization of bone morphogenetic protein-2 and -3 and osteogenic protein-1 during murine tooth root morphogenesis and in other craniofacial structures. Eur. J. Oral Sci. 107: 368-377.
http://dx.doi.org/10.1046/j.0909-8836.1999.eos107508.x
PMid:10515202
Valdes AM, Hart DJ, Jones KA, Surdulescu G, et al. (2004). Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Arthritis Rheum. 50: 2497-2507.
http://dx.doi.org/10.1002/art.20443
PMid:15334463
Valdes AM, Van Oene M, Hart DJ, Surdulescu GL, et al. (2006). Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women. Arthritis Rheum. 54: 533-539.
http://dx.doi.org/10.1002/art.21621
PMid:16453284
van den Boogaard MJ, Dorland M, Beemer FA and van Amstel HK (2000). MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat. Genet. 24: 342-343.
http://dx.doi.org/10.1038/74155
PMid:10742093
Wang H, Liu D, Yang Z, Tian B, et al. (2008). Association of bone morphogenetic protein-2 gene polymorphisms with susceptibility to ossification of the posterior longitudinal ligament of the spine and its severity in Chinese patients. Eur. Spine J. 17: 956-964.
http://dx.doi.org/10.1007/s00586-008-0651-8
PMid:18389292 PMCid:2443260
Zhang H and Bradley A (1996). Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122: 2977-2986.
PMid:8898212